Back to News
research

Nektar Therapeutics (NKTR) Discusses Topline Results From REZOLVE-AA Phase 2b Study of rezpegaldesleukin in Alopecia Areata - Slideshow

Seeking Alpha
Loading...
1 min read
2 views
0 likes
Nektar Therapeutics (NKTR) Discusses Topline Results From REZOLVE-AA Phase 2b Study of rezpegaldesleukin in Alopecia Areata - Slideshow

Summarize this article with:

SA Transcripts157.38K FollowersFollow5ShareSaveCommentsThe following slide deck was published by Nektar Therapeutics in conjunction with this event. This article was written bySA Transcripts157.38K FollowersFollowSeeking Alpha's transcripts team is responsible for the development of all of our transcript-related projects. We currently publish thousands of quarterly earnings calls per quarter on our site and are continuing to grow and expand our coverage. The purpose of this profile is to allow us to share with our readers new transcript-related developments. Thanks, SA Transcripts Team

Read Original

Source Information

Source: Seeking Alpha